The Hwang Saga Continues: A Genetic Crossroads Exclusive
By Pete Shanks,
Genetic Crossroads
| 05. 12. 2006
|
Seoul National University
|
The downfall of South Korean cloning researcher Hwang Woo-Suk, formerly his country's "supreme scientist," continues to play out. Prosecutors have announced that Hwang and his associate Kim Sun-jong will be indicted on charges related to the unethical and illegal procurement of women's eggs. They are still considering criminal charges related to the scientific fraud itself and to embezzlement of government funds. Seoul National University (SNU) has announced that the buildings intended for the ill-fated World Stem Cell Hub, created by Hwang last fall, will now be used for a gene-therapy center focusing on work with adult stem cells.
CGS associate Pete Shanks visited Seoul in April to investigate the scandal further:
Seoul, the capital of South Korea is a huge, modern, vibrant megalopolis. "I didn't like California so much," commented one Korean activist, "Too slow. New York, that's more my speed."
South Korea as a whole is one of the most rapidly urbanizing countries on the planet - more than 80% urban, up from 57% 25 years ago. It has the 9th largest economy in the...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...